Nuveen Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History

Nuveen Asset Management, LLC

  • $334 Billion
  • Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 804,350 shares of VRTX stock, worth $404 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
804,350
Previous 835,717 3.75%
Holding current value
$404 Million
Previous $349 Million 7.92%
% of portfolio
0.11%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
SELL
$392.81 - $485.53 $12.3 Million - $15.2 Million
-31,367 Reduced 3.75%
804,350 $377 Million
Q1 2024

May 13, 2024
SELL
$407.69 - $446.08 $2.2 Million - $2.41 Million
-5,406 Reduced 0.64%
835,717 $349 Million
Q4 2023

Feb 14, 2024
BUY
$343.0 - $410.68 $9.79 Million - $11.7 Million
28,536 Added 3.51%
841,123 $342 Million
Q3 2023

Nov 14, 2023
SELL
$338.18 - $362.46 $13.3 Million - $14.3 Million
-39,405 Reduced 4.63%
812,587 $283 Million
Q2 2023

Aug 14, 2023
SELL
$314.42 - $351.91 $17.7 Million - $19.8 Million
-56,336 Reduced 6.2%
851,992 $300 Million
Q1 2023

May 15, 2023
SELL
$283.23 - $323.1 $482,340 - $550,239
-1,703 Reduced 0.19%
908,328 $286 Million
Q4 2022

Feb 14, 2023
SELL
$285.76 - $321.48 $121 Million - $137 Million
-424,810 Reduced 31.82%
910,031 $263 Million
Q3 2022

Nov 14, 2022
BUY
$273.83 - $305.53 $22.7 Million - $25.3 Million
82,937 Added 6.62%
1,334,841 $386 Million
Q2 2022

Aug 15, 2022
SELL
$234.96 - $292.55 $1.37 Million - $1.71 Million
-5,830 Reduced 0.46%
1,251,904 $353 Million
Q1 2022

May 16, 2022
SELL
$221.42 - $260.97 $19.1 Million - $22.5 Million
-86,100 Reduced 6.41%
1,257,734 $315 Million
Q4 2021

Feb 14, 2022
SELL
$177.01 - $223.45 $3.79 Million - $4.78 Million
-21,391 Reduced 1.57%
1,343,834 $295 Million
Q3 2021

Nov 12, 2021
SELL
$181.39 - $202.99 $261 Million - $293 Million
-1,441,437 Reduced 51.36%
1,365,225 $248 Million
Q2 2021

Aug 16, 2021
BUY
$187.49 - $221.1 $11.9 Million - $14 Million
63,271 Added 2.31%
2,806,662 $566 Million
Q1 2021

May 17, 2021
BUY
$207.02 - $241.31 $25.2 Million - $29.4 Million
121,953 Added 4.65%
2,743,391 $590 Million
Q4 2020

May 17, 2021
SELL
$207.01 - $276.09 $3.38 Million - $4.5 Million
-16,316 Reduced 0.62%
2,621,438 $620 Million
Q4 2020

Feb 16, 2021
SELL
$207.01 - $276.09 $179 Million - $239 Million
-864,201 Reduced 24.68%
2,637,754 $623 Million
Q3 2020

Nov 16, 2020
BUY
$255.65 - $303.1 $6.03 Million - $7.14 Million
23,572 Added 0.68%
3,501,955 $953 Million
Q2 2020

Aug 14, 2020
BUY
$225.48 - $295.8 $164 Million - $215 Million
726,720 Added 26.41%
3,478,383 $1.01 Billion
Q1 2020

May 14, 2020
BUY
$199.77 - $247.81 $47.7 Million - $59.1 Million
238,591 Added 9.49%
2,751,663 $655 Million
Q4 2019

Feb 14, 2020
BUY
$166.71 - $223.91 $74.3 Million - $99.8 Million
445,821 Added 21.57%
2,513,072 $550 Million
Q3 2019

Nov 14, 2019
SELL
$166.23 - $187.09 $39.9 Million - $44.9 Million
-240,152 Reduced 10.41%
2,067,251 $350 Million
Q2 2019

Aug 15, 2019
BUY
$164.61 - $190.37 $377 Million - $436 Million
2,292,058 Added 14936.84%
2,307,403 $423 Million
Q1 2019

May 14, 2019
SELL
$163.73 - $194.7 $491 - $584
-3 Reduced 0.02%
15,345 $2.82 Million
Q4 2018

Feb 14, 2019
SELL
$151.91 - $192.21 $16,406 - $20,758
-108 Reduced 0.7%
15,348 $2.54 Million
Q3 2018

Nov 13, 2018
SELL
$167.73 - $192.74 $82,187 - $94,442
-490 Reduced 3.07%
15,456 $2.98 Million
Q2 2018

Aug 14, 2018
SELL
$145.72 - $169.96 $346,085 - $403,655
-2,375 Reduced 12.96%
15,946 $2.71 Million
Q1 2018

May 14, 2018
SELL
$151.6 - $177.13 $1.38 Million - $1.61 Million
-9,076 Reduced 33.13%
18,321 $2.99 Million
Q4 2017

Feb 14, 2018
SELL
$137.28 - $155.55 $8.39 Million - $9.51 Million
-61,138 Reduced 69.06%
27,397 $0
Q3 2017

Nov 14, 2017
BUY
$148.13 - $162.24 $13.1 Million - $14.4 Million
88,535
88,535 $13.5 Million

Others Institutions Holding VRTX

# of Institutions
1,716
Shares Held
225M
Call Options Held
1.19M
Put Options Held
1.56M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email